Standard InChI: InChI=1S/C37H51N5O3.2ClH/c1-37(2,3)29-8-4-26(5-9-29)33-22-27(7-11-34(33)45-32-12-15-40-25-32)36(43)42-18-13-31(14-19-42)44-35-23-30(10-6-28(35)24-38)41-20-16-39-17-21-41;;/h6-7,10-11,22-23,26,29,31-32,39-40H,4-5,8-9,12-21,25H2,1-3H3;2*1H/t26?,29?,32-;;/m0../s1
Standard InChI Key: BJLUZOOHVQRTRQ-BZWZXOHXSA-N
Associated Targets(Human)
CTNNB1Tchembeta-catenin-B-cell lymphoma 9 protein complex (525 Activities)
1.Li Z, Zhang M, Teuscher KB, Ji H.. (2021) Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction., 64 (15.0):[PMID:34270257][10.1021/acs.jmedchem.1c00596]
2.Li Z, Zhang M, Teuscher KB, Ji H.. (2021) Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction., 64 (15.0):[PMID:34270257][10.1021/acs.jmedchem.1c00596]
3.Li Z, Zhang M, Teuscher KB, Ji H.. (2021) Discovery of 1-Benzoyl 4-Phenoxypiperidines as Small-Molecule Inhibitors of the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction., 64 (15.0):[PMID:34270257][10.1021/acs.jmedchem.1c00596]